Merck: Schering-Plough integration is track
Merck said it’s been building sales of key products and launching new products since the Nov. 3 acquisition.
Read more on The Record and Herald News
Breathe Well Live Well
Merck: Schering-Plough integration is track
Merck said it’s been building sales of key products and launching new products since the Nov. 3 acquisition.
Read more on The Record and Herald News
When Treating One Worker’s Allergy Sets Off Another’s
When one employee needs a service dog to work and another employee is allergic to dogs, what’s an employer to do to remain within the law?
Read more on New York Times
RFS burn-off sparks bushfire fear
A MAJOR Rural Fire Service burn-off in western Sydney sparked a flood of panicked calls to triple-0 by residents fearing a bushfire had broken out.
Read more on Daily Telegraph
Merck: Schering-Plough integration is on track
Merck: Integration of new Schering-Plough unit is on track, new drugs are approaching approval
Read more on Bay News 9 Tampa Bay
Merck Says Schering-Plough Integration On Track
Drugmaker said its integration of Schering Plough is off to a good start, with sales and other operations already combined in the top 20 countries where they operate.
Read more on Manufacturing.net
Teen speaks out boldly to dispel myths about Tourette’s syndrome
During his first public presentation as Youth Ambassador for the National Tourette Syndrome Association, 14-year-old Nathaniel Ray was bombarded with questions from fifth-graders at Stone Lakes Elementary in Orlando last week.
Read more on Orlando Sentinel
(AFX UK Focus) 2010-05-11 17:47 UPDATE 3-Merck to seek 5 new drug approvals this year
By Lewis Krauskopf and Ransdell Pierson
Read more on Interactive Investor
News 5.10.2010
Array
Read more on Radio Prague
Sydneysiders urged to avoid smoke haze
Sydneysiders are being urged to stay indoors as a thick smoke haze sweeps across the city following hazard reduction burns in the Blue Mountains.
Read more on The Age
Press Release
Merck & Co. Inc. Posted on:11 May 10 Merck & Co., Inc. (NYSE:MRK) today hosted its first R&D and Business Briefing since the completion of the Merck and Schering-Plough merger.
Read more on PharmiWeb